Journal of NeuroinflammationNeurosciencePeer-reviewed journal article
Metabolic reprogramming and altered ATP content impair neuroprotective functions of microglia in β-glucocerebrosidase deficiency models
Electra BrunialtiiD, Alessandro Maria VillaiD, Éva M. SzegőiD, Pietro La VitolaiD, Denise DragoiD, Radmila PavlovićiD, Laura FontanaiD, Doga Tuna, Alessia PanzeriiD, Clara MedaiD, Christin WeisslederiD, Ornella RondinoneiD, Mattia PitasiiD, Monica Rosa MiozzoiD, Michela DeleidiiD, Annapaola AndolfoiD, Donato A. Di MonteiD, Paolo CianaiD
Abstract
Mutations in the GBA gene, which reduce {beta}-glucocerebrosidase (GCase) activity, represent the most significant genetic risk factor for Parkinsons disease (PD). Decreased GCase activity has also been observed in sporadic PD cases, supporting a broader role for GCase in the poorly understood mechanisms underlying PD etiopathogenesis. While most studies on the relationship between GBA mutations and PD have focused on neurons, evidence suggests that PD pathology promoted by GCase deficiency involves other cell types and, in particular, interactions between neuronal and glial cells. Here, we identify microglia as primary players undergoing significant alterations at early stages of the pathological processes triggered by a GCase impairment. Using both pharmacological and genetic mouse models of GCase deficiency, we observed microglial morphological, transcriptional and metabolic changes. Interestingly, these changes were associated with a cell-specific, significant reduction of microglial ATP levels. When microglial ATP depletion was reproduced in an in vitro system of co-cultured microglial and neuronal cells, the neuroprotective properties of microglia were compromised and neuronal susceptibility to oxidative stress was enhanced. These findings underscore the role of microglia in PD pathogenesis and point to a pathogenetic mechanism by which microglial metabolic disturbances leading to ATP depletion enhance neuronal vulnerability to injury and neurodegeneration. This mechanism could be targeted for therapeutic intervention aimed at mitigating PD risk and counteracting the development of PD pathology. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=112 SRC="FIGDIR/small/656111v2_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@dfd3d7org.highwire.dtl.DTLVardef@ccf2c2org.highwire.dtl.DTLVardef@155d241org.highwire.dtl.DTLVardef@15ed00a_HPS_FORMAT_FIGEXP M_FIG C_FIG
- Citations
- 4
- FWCI
- 1.43
- Field percentile
- top 18%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Inhibition of microglial GBA hampers the microglia-mediated anti-oxidant and protective response in neurons
Electra Brunialti, Alessandro Maria Villa, … Paolo Ciana·Journal of NeuroinflammationPeer-reviewed·Sep 22, 2021
- Sex-specific microglial responses to glucocerebrosidase inhibition: relevance to GBA1-linked Parkinson disease
Electra Brunialti, Alessandro Maria Villa, … Paolo Ciana·CellsPeer-reviewed·Jan 17, 2023
- Glucocerebrosidase Deficiency Dysregulates Human Astrocyte Lipid Metabolism
Aboud Tahanis, Thao Nguyen, … Robert Krencik·bioRxiv·Jan 9, 2025
- Glucocerebrosidase deficiency leads to neuropathology via cellular immune activation
Evelyn S. Vincow, Ruth E. Thomas, … Leo J. Pallanck·PLoS GeneticsPeer-reviewed·Nov 11, 2024
- Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells
P. Mistry, C. S. Boddupalli, … S. Nair·bioRxiv·May 13, 2022
- Microglial GSDMD-Mediated Pyroptosis Drives Neuroinflammation in Parkinson's Disease
Mengmeng Wang, Yuedong Wang, … You Yin·bioRxiv·Jun 30, 2025